Literature DB >> 25586186

Scaffold protein JLP is critical for CD40 signaling in B lymphocytes.

Hui-ming Wang1, Qi Yan2, Tao Yang2, Hui Cheng2, Juan Du2, Katsuji Yoshioka3, Sam K P Kung4, Guo-hua Ding5.   

Abstract

CD40 expression on the surface of B lymphocytes is essential for their biological function and fate decision. The engagement of CD40 with its cognate ligand, CD154, leads to a sequence of cellular events in B lymphocytes, including CD40 cytoplasmic translocation, a temporal and spatial organization of effector molecules, and a cascade of CD40-induced signal transduction. The JLP scaffold protein was expressed in murine B lymphocytes. Using B lymphocytes from jlp-deficient mice, we observed that JLP deficiency resulted in defective CD40 internalization upon CD154/CD40 engagement. Examination of interactions and co-localization among CD40, JLP, dynein, and Rab5 in B lymphocytes suggested that CD40 internalization is a process of JLP-mediated vesicle transportation that depends on Rab5 and dynein. JLP deficiency also diminished CD40-dependent activation of MAPK and JNK, but not NF-κB. Inhibiting vesicle transportation from the direction of cell periphery to the cell center by a dynein inhibitor (ciliobrevin D) impaired both CD154-induced CD40 internalization and CD40-dependent MAPK activities in B lymphocytes. Collectively, our data demonstrate a novel role of the JLP scaffold protein in the bridging of CD154-triggered CD40 internalization and CD40-dependent signaling in splenic B lymphocytes.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell Signaling; Mitogen-activated Protein Kinase (MAPK); Receptor; Scaffold Protein; Trafficking

Mesh:

Substances:

Year:  2015        PMID: 25586186      PMCID: PMC4342446          DOI: 10.1074/jbc.M114.618496

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 2.  Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.

Authors:  John P Graham; Kelly M Arcipowski; Gail A Bishop
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 3.  Scaffold proteins and immune-cell signalling.

Authors:  Andrey S Shaw; Erin L Filbert
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

4.  Ceramide-rich membrane rafts mediate CD40 clustering.

Authors:  Heike Grassmé; Verena Jendrossek; Jürgen Bock; Andrea Riehle; Erich Gulbins
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

Review 5.  Traffic control: regulation of kinesin motors.

Authors:  Kristen J Verhey; Jennetta W Hammond
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

Review 6.  Expanding TRAF function: TRAF3 as a tri-faced immune regulator.

Authors:  Hans Häcker; Ping-Hui Tseng; Michael Karin
Journal:  Nat Rev Immunol       Date:  2011-06-10       Impact factor: 53.106

7.  The Caenorhabditis elegans JIP3 protein UNC-16 functions as an adaptor to link kinesin-1 with cytoplasmic dynein.

Authors:  Makoto Arimoto; Sandhya P Koushika; Bikash C Choudhary; Chris Li; Kunihiro Matsumoto; Naoki Hisamoto
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

8.  A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Piao Lo; Nicholas Terry; Pamela S Reid; Richard J Ford
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

9.  Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules.

Authors:  K J Verhey; D Meyer; R Deehan; J Blenis; B J Schnapp; T A Rapoport; B Margolis
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

Review 10.  Walking the walk: how kinesin and dynein coordinate their steps.

Authors:  Arne Gennerich; Ronald D Vale
Journal:  Curr Opin Cell Biol       Date:  2009-01-27       Impact factor: 8.382

View more
  6 in total

1.  B Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-κB Activation for Antibody Class-Switching.

Authors:  Hui Yan; Maria Fernandez; Jingwei Wang; Shuai Wu; Rui Wang; Zheng Lou; Justin B Moroney; Carlos E Rivera; Julia R Taylor; Huoqun Gan; Hong Zan; Dmytro Kolvaskyy; Dongfang Liu; Paolo Casali; Zhenming Xu
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

2.  CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade.

Authors:  Theodoros Giavridis; Sjoukje J C van der Stegen; Justin Eyquem; Mohamad Hamieh; Alessandra Piersigilli; Michel Sadelain
Journal:  Nat Med       Date:  2018-05-28       Impact factor: 53.440

3.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

Review 4.  The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.

Authors:  Manel B Hammouda; Amy E Ford; Yuan Liu; Jennifer Y Zhang
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

5.  A negative feedback loop between JNK-associated leucine zipper protein and TGF-β1 regulates kidney fibrosis.

Authors:  Qi Yan; Kai Zhu; Lu Zhang; Qiang Fu; Zhaowei Chen; Shan Liu; Dou Fu; Ryota Nakazato; Katsuji Yoshioka; Bo Diao; Guohua Ding; Xiaogang Li; Huiming Wang
Journal:  Commun Biol       Date:  2020-06-05

Review 6.  Ciliobrevins as tools for studying dynein motor function.

Authors:  Douglas H Roossien; Kyle E Miller; Gianluca Gallo
Journal:  Front Cell Neurosci       Date:  2015-07-06       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.